These are short definitions for terms used across gout-care.
The definitions are written for adults who may not have medical or science background. Plain does not mean childish. It means the word should make sense without sending you to another tab.
In the site, glossary links should open the definition inline when possible. The full glossary page is here for readers who want the list in one place.
When a glossary term has a deeper mechanism page, the entry includes a source link after the plain-language explanation.
ABCG2
A transport protein that helps move urate out of cells and into places where it can leave the body, including the gut.
Why it matters: some people may have weaker urate clearance because of transporter biology. That can make gout less about one meal and more about how the body handles urate over time.
Deeper source: ABCG2 modulators
Active flare
A gout episode that is already underway: pain, heat, swelling, redness, touch sensitivity, stiffness, or trouble using the joint.
Why it matters: active flare advice is different from prevention advice.
Deeper source: Gout action guide
Allopurinol
A prescription urate-lowering medicine. It lowers uric acid production by blocking xanthine oxidase, an enzyme in the uric-acid production path.
Why it matters: allopurinol is a long-term crystal-burden medicine, not a pain-now medicine. Starting or changing it can need a flare-protection plan.
Deeper source: Gout pathophysiology
AMP
Short for adenosine monophosphate, a molecule involved in cellular energy handling.
Why it matters: concentrated fructose can push energy chemistry toward AMP breakdown, which can increase uric acid production.
Deeper source: Fructose connection
ATP
Short for adenosine triphosphate, a main energy-carrying molecule in cells.
Why it matters: fructose metabolism can drain ATP quickly in some contexts. That ATP drop is part of the uric-acid production story.
Deeper source: Fructose connection
Baseline
Your normal-for-you level of pain, stiffness, swelling, or sensitivity in a joint when you are not actively flaring.
Why it matters: a change from your baseline can be an early signal, even if someone else's baseline is different.
Deeper source: Self-experiment protocol
Beta-caryophyllene
A terpene found in some plants, including cannabis and black pepper. It can interact with CB2, an immune-related receptor.
Why it matters: beta-caryophyllene has gout-relevant animal evidence involving monosodium urate crystals. That is not the same as a proven human gout protocol, but it is more specific than generic "relaxation" language.
Deeper source: Cannabinoids and terpenes
Beta-glucan
A type of fiber found in oats, barley, mushrooms, yeast, and some supplements.
Why it matters: beta-glucans can have immune and gut effects, but product source and structure matter. Do not treat every "beta-glucan" label as the same intervention.
Deeper source: Supplements stack
BHB
Short for beta-hydroxybutyrate, a ketone the body makes during fasting, carbohydrate restriction, or other ketosis states.
Why it matters: BHB has interesting NLRP3-related mechanisms, but ketosis can also raise serum urate for some people. That makes it state-dependent, not a pain-now shortcut.
Deeper source: Beta-hydroxybutyrate
C5a
An immune signal made when the complement system turns on.
Why it matters: in gout, C5a can help prime immune cells around urate crystals. It is one reason the flare cascade can start before NLRP3 gets all the attention.
Deeper source: Complement C5a in gout
CB2
An immune-related cannabinoid receptor.
Why it matters: some cannabinoid and terpene mechanisms are relevant to inflammation through CB2 and related pathways. That does not automatically prove a product works for gout, but it gives a real mechanism to evaluate.
Deeper source: Cannabinoids and terpenes
Cannabinoid
A compound that interacts with the body's cannabinoid system. THC and CBD are common examples from cannabis.
Why it matters: cannabinoids can matter for pain, sleep, and inflammatory signaling, depending on product, route, legality, dose, and personal fit. A mechanism is not the same as a proven gout treatment.
Deeper source: Cannabinoids and terpenes
Carnosine
A small molecule made from two amino acids. It is also sold as L-carnosine.
Why it matters: carnosine is an intentional experiment lane in gout-care because of urate and NLRP3-adjacent animal/mechanism evidence. Track it like an experiment, not a guaranteed treatment.
Deeper source: Carnosine
CKD
Short for chronic kidney disease, meaning the kidneys have reduced function over time.
Why it matters: kidneys are central to urate clearance. CKD can change urate levels, medicine fit, dosing questions, and what labs need monitoring.
Deeper source: Gout pathophysiology
Colchicine
A prescription medicine used in gout care. It changes how certain immune cells move and react during inflammation.
Why it matters: colchicine is used for flares and sometimes flare prevention during urate-lowering transitions. Timing, kidney/liver function, interactions, and the plan written for you matter.
Deeper source: Colchicine
Complement
A fast immune-alert system in the blood and tissues.
Why it matters: in gout, complement can add fuel to the immune response around urate crystals. Crystals are not the whole flare. Immune amplification helps explain why a quiet joint can become explosively painful.
Deeper source: Complement C5a in gout
Cordycepin
A compound associated with some Cordyceps mushroom research.
Why it matters: cordycepin is not the same thing as a generic Cordyceps product. If a product implies cordycepin effects, the label and testing need to show what is actually present.
Deeper source: Medicinal mushroom complement track
Corticosteroid
A medicine that reduces inflammation. Prednisone is one common example.
Why it matters: corticosteroids are one current-care category for gout flares, but fit depends on the person: glucose, blood pressure, infection risk, mood/sleep effects, other conditions, and the clinician's plan.
Deeper source: Gout action guide
Creatinine
A blood marker often used to estimate kidney function.
Why it matters: kidney function affects urate clearance and the fit of several gout medicines.
Deeper source: Gout action guide
Diuretic
A medicine that makes the body lose more salt and water through urine. Some are used for blood pressure, heart failure, swelling, or other conditions.
Why it matters: some diuretics can raise urate or change gout risk. If a flare pattern changes after a medication change, the medication timeline is worth bringing to the visit.
Deeper source: Gout action guide
Dual-energy CT
An imaging test that can help identify urate crystal deposits.
Why it matters: it can be useful when the diagnosis is uncertain, when joint fluid testing is not available, or when crystal burden needs a clearer look.
eGFR
Estimated glomerular filtration rate. It is a lab-based estimate of how well the kidneys are filtering.
Why it matters: eGFR helps clinicians judge kidney function, urate handling, and medication fit.
Deeper source: Gout action guide
FEUA
Fractional excretion of urate. It is a test calculation that estimates how much urate the kidneys are letting leave in urine.
Why it matters: it can sometimes help separate under-excretion from overproduction questions, especially in early, unusual, familial, stone-linked, medication-linked, or hard-to-control patterns.
Deeper source: Gout action guide
Febuxostat
A prescription urate-lowering medicine. Like allopurinol, it lowers uric acid production by blocking xanthine oxidase.
Why it matters: febuxostat is a long-term urate medicine, not a pain-now medicine. Cardiovascular history and clinician fit matter.
Deeper source: Gout pathophysiology
Flare threshold
The point where your system tips from quiet or mildly irritated into an active flare.
Why it matters: dehydration, illness, poor sleep, medication changes, mechanical stress, alcohol, concentrated fructose, or other factors may lower the threshold.
Deeper source: Gout action guide
G6PD
An enzyme that helps protect red blood cells from certain kinds of stress.
Why it matters: G6PD testing matters before some medicines, including systemic uricase therapy, because deficiency can create serious risk.
Deeper source: Uricase
GLUT9
A urate transport protein, especially important in kidney urate handling.
Why it matters: transporters like GLUT9 help explain why gout risk differs across people even with similar diets.
Deeper source: Gout pathophysiology
HLA-B*58:01
A genetic marker linked to higher risk of a rare but serious allopurinol reaction.
Why it matters: some guidelines recommend discussing testing before allopurinol in people with higher-risk ancestry or clinical context.
Deeper source: Gout action guide
IL-1 beta
An inflammatory message released by immune cells.
Why it matters: in gout, IL-1 beta helps drive pain, swelling, heat, and immune-cell recruitment. It is one of the main signals after NLRP3 turns on.
Deeper source: NLRP3 inflammasome
Ketosis
A metabolic state where the body is making more ketones, often during fasting, very-low-carbohydrate eating, or some illness and diabetes contexts.
Why it matters: ketosis can be complicated for gout. It may raise serum urate in the short term while BHB has interesting NLRP3-related mechanisms. State and measurement matter.
Deeper source: Beta-hydroxybutyrate
Macrophage
An immune cell that can swallow debris, germs, or crystals and then send inflammatory signals.
Why it matters: in gout, macrophages can take up urate crystals and help start the NLRP3/IL-1 beta cascade.
Deeper source: NLRP3 inflammasome
Monosodium urate
The crystal form of urate involved in gout. You may see it shortened as MSU.
Why it matters: monosodium urate crystals can sit quietly in tissue, then become the setting for an immune flare.
Deeper source: Gout pathophysiology
MSU
Short for monosodium urate.
Why it matters: MSU is common research shorthand for the urate crystals involved in gout.
Deeper source: Gout pathophysiology
NLRP3
A danger-sensing machine inside some immune cells.
Why it matters: in gout, urate crystals can help turn NLRP3 on. Once on, it helps release IL-1 beta and can drive a flare.
Deeper source: NLRP3 inflammasome
NSAID
Short for nonsteroidal anti-inflammatory drug. Ibuprofen and naproxen are common examples.
Why it matters: NSAIDs are one current-care medicine category for gout flares. They are not a fit for everyone, especially with some kidney, stomach, bleeding, blood pressure, heart, alcohol, or medication-interaction contexts.
Deeper source: Gout action guide
Neutrophils
Fast-arriving immune cells that show up during inflammation.
Why it matters: neutrophil recruitment helps explain why the flare can escalate quickly.
Deeper source: NLRP3 inflammasome
NF-kB
An inflammatory control switch inside cells. It helps turn on genes involved in immune signaling.
Why it matters: NF-kB is part of the priming side of the inflammatory cascade. Some interventions aim at this lane indirectly, but that needs evidence labels and tracking.
Deeper source: NLRP3 inflammasome
N-of-1
A structured self-experiment in one person.
Why it matters: gout patterns can be personal. An n-of-1 log can help preserve signal, but it does not prove the same result applies to everyone.
Deeper source: Self-experiment protocol
Nrf2
A cellular defense pathway involved in antioxidant and stress-response genes.
Why it matters: some food and supplement discussions, including sulforaphane, point at Nrf2. That can be relevant to inflammation and transport biology, but the effect depends on dose, form, state, and evidence tier.
Deeper source: ABCG2 modulators
OAT transporters
A family of transport proteins involved in moving substances, including urate-related compounds, through the kidney.
Why it matters: urate handling is not a simple drain. Transporters help decide how much urate stays in the blood and how much leaves.
Deeper source: Gout pathophysiology
Omega-3
A family of fats found in fish, algae, and some supplements.
Why it matters: omega-3s are often discussed for inflammation and resolution biology. For gout-care, the question is not "anti-inflammatory good?" It is evidence tier, dose, product quality, state fit, and what signal you track.
Deeper source: SPM resolution pathway
Pegloticase
A prescription uricase medicine used in selected severe or refractory gout cases.
Why it matters: it is a specialized treatment with infusion planning, monitoring, and safety checks. It is different from common daily urate-lowering pills.
Deeper source: Uricase
P2X7
An immune-cell signal channel involved in inflammatory activation.
Why it matters: P2X7 is one of the mechanism lanes connected to NLRP3 activation and some cannabinoid-pathway discussions.
Deeper source: Cannabinoids and terpenes
Prodrome
An early warning phase before a full flare. It might feel like a twinge, warmth, stiffness, pressure, extra sensitivity, or a small pain jump above your baseline.
Why it matters: some people can use their usual early-warning phase to follow their written flare plan sooner. That may reduce severity, but not everyone gets a clear warning.
Deeper source: Gout action guide
Probenecid
A prescription uricosuric medicine that helps the kidneys send more urate into urine.
Why it matters: it is one way to lower urate, but kidney function, stone history, urine uric acid, and drug interactions matter.
Deeper source: Gout pathophysiology
Purines
Building blocks found in your own cells and in some foods.
Why it matters: when purines break down, uric acid is produced. This is normal biology. Gout is about load plus clearance over time, not just eating one purine-containing food.
Deeper source: Gout pathophysiology
Serum urate
The amount of urate measured in the blood. It is often reported as serum uric acid.
Why it matters: staying above the crystal-forming range over time can allow urate crystals to form or persist.
Deeper source: Gout pathophysiology
SGLT2 inhibitors
A class of medicines used for diabetes, kidney disease, heart failure, and related metabolic conditions.
Why it matters: they can affect metabolism, hydration, and urate handling. If a medication change lines up with a flare pattern, bring the timeline instead of guessing.
Deeper source: Beta-hydroxybutyrate
SPM
Short for specialized pro-resolving mediator, a class of molecules involved in helping inflammation resolve.
Why it matters: ending a flare is not only "turn inflammation off." Resolution biology is part of why recovery can be clean or messy.
Deeper source: SPM resolution pathway
Sulforaphane
A compound made from glucoraphanin, especially in broccoli sprouts and related foods.
Why it matters: sulforaphane is discussed because of Nrf2, ABCG2, and NLRP3-adjacent rationale. Food handling, supplement form, and actual yield matter.
Deeper source: ABCG2 modulators
Terpene
A plant compound that often contributes smell or flavor and can also have biological effects.
Why it matters: cannabis and mushroom product claims often mention terpenes. A terpene claim should still name the compound, route, amount, evidence tier, and tracking signal.
Deeper source: Cannabinoids and terpenes
Tophi
Lumps or deposits of urate crystal material that can form in tissue after long-standing crystal burden.
Why it matters: tophi can change the target, imaging questions, and urgency of long-term urate control.
Deeper source: Gout pathophysiology
Treat-to-target
A care approach that treats serum urate as a number to reach and monitor, not a vague goal.
Why it matters: gout prevention usually depends on getting urate below the crystal-forming range and keeping it there long enough for crystal burden to fall.
Deeper source: Gout action guide
Urate
Urate is the form uric acid mostly takes in your blood and joint fluid.
Why it matters: monosodium urate crystals are the crystal deposits involved in gout.
Deeper source: Gout pathophysiology
Urate-lowering therapy
Medicines that lower uric acid over time, either by helping the body make less or remove more. Common names include allopurinol, febuxostat, and probenecid.
Why it matters: these medicines are different from flare rescue medicines. They target long-term crystal burden rather than immediate pain.
Deeper source: Gout action guide
URAT1
A kidney urate transporter.
Why it matters: URAT1 helps move urate back into the blood. Some medicines target this lane to help more urate leave in urine.
Deeper source: Gout pathophysiology
Uricosuric
A medicine or effect that helps more urate leave through urine.
Why it matters: uricosuric approaches can lower serum urate, but kidney function, stone history, urine uric acid, and drug interactions matter.
Deeper source: Gout pathophysiology
Uric acid
A normal breakdown product from purines, which come from normal cell turnover and some foods. The body clears uric acid mainly through the kidneys, with gut handling also part of the story.
Why it matters: gout is usually about uric acid load and clearance over time, not one bad meal.
Deeper source: Gout pathophysiology
Uricase
An enzyme that breaks uric acid into allantoin, a more soluble molecule.
Why it matters: most mammals have uricase. Humans do not have a functional version, which is one reason humans live closer to the chemistry where urate can form crystals. Some specialized gout treatments use uricase.
Deeper source: Uricase
Xanthine oxidase
An enzyme involved in making uric acid.
Why it matters: allopurinol and febuxostat lower uric acid by blocking this enzyme.
Deeper source: Gout pathophysiology
Xanthine oxidase inhibitor
A medicine category that lowers uric acid production by blocking xanthine oxidase.
Why it matters: allopurinol and febuxostat are xanthine oxidase inhibitors. They target long-term urate burden, not immediate pain.
Deeper source: Gout pathophysiology
Sources and deeper reading
Mechanism source links:
- Gout action guide
- Gout pathophysiology
- Fructose connection
- NLRP3 inflammasome
- Complement C5a in gout
- Colchicine
- ABCG2 modulators
- Beta-hydroxybutyrate
- Uricase
- Cannabinoids and terpenes
- Carnosine
- Androgen-urate axis
- Supplements stack
- Medicinal mushroom complement track
- Self-experiment protocol
- SPM resolution pathway
Standard-care anchors: